Bold Capital Partners

Bold Capital Partners is a venture capital firm founded in 2015 and based in Santa Monica, California, with an additional office in Los Altos, California. The firm specializes in early-stage and growth capital investments, focusing primarily on technology companies. Its investment portfolio includes sectors such as life sciences, healthcare, and frontier technology, reflecting a commitment to supporting innovative companies that have the potential for significant impact.

Will Borthwick

Principal

Teymour Boutros-Ghali

Managing Partner

Maxx Bricklin

Partner

Felicia Hsu

Investor

William Meeker

CFO

Ysette Witteveen

Investment Partner

Helen McBride Ph.D

Operating Partner

97 past transactions

Chef Robotics

Series A in 2025
Chef Robotics is a robotics and artificial intelligence company serving the food industry. The company was founded in 2019 and is headquartered in San Francisco, California.

Feno

Seed Round in 2024
Feno is leading the charge in revolutionizing the oral health industry, recognizing the crucial link between oral health and overall health. Poor oral health has been linked to serious conditions like heart disease, stroke, and diabetes, which is why we are committed to developing innovative solutions that promote better oral health and, ultimately, better overall health. Our cutting-edge products include the 20-second Feno Smartbrush, an at-home oral scanner, and AI powered digital oral health choaches, which leverage the scans to assess and analyze oral health conditions. Our mission is to empower individuals to take control of their oral health to improve their overall health.

Viome

Series D in 2024
Viome, Inc. is a biotechnology company based in Bellevue, Washington, founded in 2016 by Naveen Jain. The company specializes in wellness monitoring kits that offer comprehensive health insights by analyzing various biological samples, including blood, urine, saliva, and stool. By examining the RNA from stool samples, Viome determines the composition of microbial communities in the digestive system, identifying different species and strains of bacteria, viruses, fungi, and other microorganisms. This analysis is integrated into a smartphone application that provides personalized recommendations for diet and lifestyle adjustments, aiding users in tracking their microbiome health, mitochondrial health, cellular health, and biological age. Viome's products are available through distributors and online, positioning the company as a leader in personalized health solutions.

Immunis

Venture Round in 2024
Immunis a private biotechnology company developing a novel treatment for age and disease-related immune decline.

Holoclara

Series A in 2024
Holoclara is an immunotherapy company focused on developing treatments for autoimmune disorders using nematode-derived molecules. The company aims to provide relief to individuals suffering from these conditions by offering a range of services that include the delivery of therapeutics derived from worm species. These molecules are identified for their potent therapeutic properties and are being developed into safe, orally available treatments. Holoclara’s initiatives are designed to enable patients to lead healthier lives while addressing the challenges posed by autoimmune disorders.

Lucidity

Seed Round in 2024
Lucidity is a multi-cloud storage management platform that optimizes storage solutions across major cloud providers such as AWS, Azure, and Google Cloud. The platform automates the adjustment of block storage in real time, ensuring that enterprises can efficiently allocate resources based on their data requirements without experiencing downtime. By streamlining cloud infrastructure management, Lucidity enables organizations to improve application performance, eliminate infrastructure disruptions, and significantly reduce cloud costs, achieving savings of up to 70%. This approach allows clients to maintain operational continuity while delivering reliable and predictable storage performance.

Synadia

Series B in 2024
Synadia Communications Inc. is a technology company based in Los Angeles, California, focused on developing a global utility platform for connecting digital systems, services, and devices. Established in 2017, Synadia is the leader in the development of NATS.io, an open-source messaging system designed for cloud-native applications, microservices architectures, and Internet of Things (IoT) messaging. The company offers NGS, a secure and globally available communications platform built on NATS.io, along with additional services such as commercial support, consulting, non-recurring engineering, and training. By leveraging its innovative technology, Synadia aims to provide scalable and secure messaging solutions that facilitate modern distributed systems across various applications.

Gallant Therapeutics

Series A in 2024
Gallant Therapeutics is an animal health biotechnology company developing allogeneic, "off-the-shelf" stem cell therapies from their stem cell platform. Gallant is also the leading provider of non-invasive stem cell banking during the spay or neuter process, opening the door to novel regenerative medical treatments formerly unavailable for non-human family members. Clinical studies demonstrate stem cell therapies help pets with a multitude of ailments, including osteoarthritis, atopic dermatitis, chronic kidney disease, and chronic stomatitis, among others. Gallant's first product helps to save cats that would die of chronic gingivostomatitis, with a robust pipeline in development for companion animals.

Mighty Buildings

Series B in 2023
Mighty Buildings, Inc. is a construction technology company based in San Francisco, California, founded in 2017. The company specializes in manufacturing 3D printed custom homes, aiming to disrupt the residential housing market through innovative techniques. Utilizing a proprietary building material known as Light Stone Material (LSM), which resembles synthetic stone, Mighty Buildings enhances the construction process by making it faster and eliminating waste. LSM also offers better temperature regulation compared to traditional materials like concrete, wood, or steel. In addition to 3D printing, Mighty Buildings employs robotics and automation to develop prefabricated, environmentally friendly, and climate-resilient homes. The company's approach to modular construction is designed to provide affordable smart housing solutions while supporting urban development.

Viome

Series C in 2023
Viome, Inc. is a biotechnology company based in Bellevue, Washington, founded in 2016 by Naveen Jain. The company specializes in wellness monitoring kits that offer comprehensive health insights by analyzing various biological samples, including blood, urine, saliva, and stool. By examining the RNA from stool samples, Viome determines the composition of microbial communities in the digestive system, identifying different species and strains of bacteria, viruses, fungi, and other microorganisms. This analysis is integrated into a smartphone application that provides personalized recommendations for diet and lifestyle adjustments, aiding users in tracking their microbiome health, mitochondrial health, cellular health, and biological age. Viome's products are available through distributors and online, positioning the company as a leader in personalized health solutions.

Solarea Bio

Series B in 2023
Solarea Bio is a biotech company that develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health. It specializes in the research and development of therapeutics that are derived from natural sources and are aimed to treat indications derived from chronic inflammation, enabling hospitals to provide medicinal drugs for improved quality of life. The company generates a large database of the complete genomic sequences of microbes derived from healthy foods. Using computational approaches, Solarea generates synergistic combinations of bacteria, fungi, and prebiotic fibers with powerful anti-inflammatory capabilities to address specific chronic conditions that afflict large numbers of people. These have been validated in-vitro and in-vivo in preclinical mouse models. Its first application aims to aid in the dietary management of the metabolic processes that cause osteopenia and osteoporosis in postmenopausal women. This provides a nature-based solution to improving women’s health and well-being. The Cambridge, Massachusetts-based company was established in 2017 by Eric Schott, Gerardo Toledo, and Jillian DeWalt.

Colossal Laboratories & Biosciences

Series B in 2023
Colossal Biosciences is a bioscience and genetic engineering company dedicated to the restoration of extinct species and the protection of endangered ones. By leveraging advanced gene editing technologies such as CRISPR, the company focuses on reviving species like the woolly mammoth and enhancing ecosystems. Colossal aims to address pressing issues related to extinction and biodiversity loss through innovative solutions that support the repopulation of critical ecosystems. Their work seeks not only to restore the natural balance of the environment but also to consider the future economic and biological needs of humanity.

Dreamscape Learn

Series A in 2023
Dreamscape Learn is an edtech company focusing on cinematic story-telling, cutting-edge immersive technologies, and advanced pedagogy. They believe that the best educational designs combine multiple pedagogical modalities. Students study; they apply knowledge and concepts; they learn by doing and do in order to learn; they learn through text, lecture, visual and audio media, hands-on experience, and from one another. They create programs and products that connect all of these modes of engagement.

Syntis Bio

Venture Round in 2023
Syntis Bio is a late-stage preclinical company focused on developing a new class of oral therapies. By utilizing innovative formulations, the company's drugs are designed to target specific tissues, which enhances bioavailability and expands treatment options across a broader range of diseases.

Earth Force

Seed Round in 2022
Earth Force is a Vegetation Management System platform.

Viome

Series C in 2022
Viome, Inc. is a biotechnology company based in Bellevue, Washington, founded in 2016 by Naveen Jain. The company specializes in wellness monitoring kits that offer comprehensive health insights by analyzing various biological samples, including blood, urine, saliva, and stool. By examining the RNA from stool samples, Viome determines the composition of microbial communities in the digestive system, identifying different species and strains of bacteria, viruses, fungi, and other microorganisms. This analysis is integrated into a smartphone application that provides personalized recommendations for diet and lifestyle adjustments, aiding users in tracking their microbiome health, mitochondrial health, cellular health, and biological age. Viome's products are available through distributors and online, positioning the company as a leader in personalized health solutions.

Gameto

Venture Round in 2022
Gameto is a biotechnology company focused on improving female reproductive health through innovative therapies. Recognizing that women's health is an underserved area with limited treatment options, Gameto aims to develop advanced solutions that enhance patient outcomes. The company utilizes cellular engineering to create female reproductive cell lines, employing proprietary combinations of transcription factors to reprogram human induced pluripotent stem cells (hiPSCs) into engineered ovarian and endometrial cell lines that function similarly to natural cells. This platform supports a portfolio of cellular therapeutics targeting various female reproductive diseases. Gameto's flagship program, Fertilo, is designed to enhance the processes of in vitro fertilization (IVF) and egg freezing, making them shorter, safer, and more effective. Additional applications of Gameto's technology include Deovo, an organoid of the female reproductive system, and Ameno, a cell-based therapeutic aimed at alleviating the health issues associated with primary ovarian insufficiency and menopause.

KeyCare

Series A in 2022
KeyCare is a virtual care platform powered by Epic that was created to assist forward-thinking health systems in increasing patient access and quality by enhancing the alternatives available for virtual care.

AliveCor

Series F in 2022
AliveCor, Inc. develops advanced mobile electrocardiogram (ECG) technology that transforms smartphones into clinical-quality heart monitoring devices. The company offers KardiaMobile, a personal ECG device for the instant detection of common heart arrhythmias, along with KardiaMobile 6L, which provides detailed 6-lead ECGs that patients can share with their healthcare providers. Additionally, AliveCor has introduced KardiaCare, a digital health subscription service that allows users to manage their heart health conveniently at home. Founded in 2010 and headquartered in Mountain View, California, AliveCor is recognized for its innovative use of machine learning techniques to enhance proactive heart care and improve stroke prevention through early atrial fibrillation detection.

Insilico Medicine

Series D in 2022
Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.

Insilico Medicine

Series D in 2022
Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.

Curebase

Series B in 2022
Curebase is a company that develops software aimed at transforming the management of clinical trials. Founded in 2017 and based in San Francisco, California, its platform facilitates faster and more cost-effective trial execution by streamlining participant eligibility, enrollment, education, and consent processes. The software automates many manual steps and allows drug companies to efficiently distribute their trials to clinics. Additionally, it provides sponsors with access to real-time data, enabling them to monitor trial progress and manage information effectively. Curebase's services cater to various sectors, including medical devices, biotechnology, and digital health startups, enhancing the overall efficiency of clinical research.

Pyka

Series A in 2022
Pyka, Inc. is a startup based in Oakland, California, that specializes in the development of autonomous electric aircraft for agricultural and cargo applications. Founded in 2016, the company focuses on creating innovative solutions that enhance safety, affordability, and accessibility in aviation. Pyka's aircraft are designed for precision spraying in agriculture, allowing for effective chemical application over diverse terrains while minimizing environmental impact. The technology incorporates advanced flight controllers and onboard sensors to ensure accuracy and efficiency in operations. Additionally, the aircraft can be utilized for cargo transportation, particularly in remote or challenging areas, showcasing their versatility. Through its commitment to sustainability and technological advancement, Pyka aims to transform traditional practices in crop protection and logistics.

Crowdz

Convertible Note in 2022
Crowdz is a company focused on modernizing the traditional trade finance industry through innovative invoicing software. By automating risk assessment at the receivable level, Crowdz provides funders with valuable insights that facilitate quick decision-making aligned with their investment strategies. The company has auto risk-rated $4.2 billion in receivables, leading to over $93 million in financing through its platform. Its technology bridges real-world assets with decentralized finance by digitizing receivables on-chain, thereby enabling small and midsize enterprises to access essential business financing and enhance their competitive edge. Crowdz has garnered significant support from notable customers and investors, including Citibank, Barclays, and Meta, and has raised over $28 million in funding to date.

Verana Networks

Series B in 2022
Verana Networks, Inc., founded in 2019 and located in Waltham, Massachusetts, specializes in developing innovative 5G Radio Access Network solutions for service providers utilizing licensed millimeter wave (mmWave) spectrum. The company focuses on this spectrum due to its potential for significant expansion in speed and capacity, essential for the successful deployment of 5G technology. Verana's equipment aims to provide gigabit wireless connectivity, enabling mobile network operators to offer enhanced 5G services such as fixed wireless access. By delivering faster speeds and increased capacity, the company supports the creation of new applications that drive incremental revenue, which is crucial for sustaining the business case for 5G.

Rugged Robotics

Series A in 2022
Rugged Robotics Inc., founded in 2018 and based in Houston, Texas, specializes in developing robotic platforms tailored for the commercial construction industry. The company’s flagship product, the Mark I, autonomously marks architectural and engineering designs directly onto concrete floors, facilitating accurate construction layout. This robotic system replaces traditional manual methods, which are often slow and prone to errors, thereby enhancing productivity and efficiency on construction sites. Rugged Robotics positions itself as a provider of layout as a service, offering solutions that not only address real-world construction challenges but also save time and reduce costs for contractors. By scaling its fleet and commercializing its technology, Rugged Robotics aims to deliver accessible, hardware-enabled solutions that significantly improve operational workflows in the construction sector.

ParkourSC

Venture Round in 2022
ParkourSC is a logistics and supply chain company founded in 2014 and headquartered in Milpitas, California. The company focuses on digital transformation within the manufacturing and pharmaceutical sectors by offering a cloud-based sensor platform. This platform creates a digital twin of the supply chain, processing billions of events per second to provide real-time diagnostic and predictive insights regarding asset location, condition, utilization, and anomaly detection. By collecting data from various sources, ParkourSC enables continuous visibility into the context and timing of materials and assets, allowing businesses to proactively predict disruptions and enhance operational efficiency.

Gameto

Series A in 2022
Gameto is a biotechnology company focused on improving female reproductive health through innovative therapies. Recognizing that women's health is an underserved area with limited treatment options, Gameto aims to develop advanced solutions that enhance patient outcomes. The company utilizes cellular engineering to create female reproductive cell lines, employing proprietary combinations of transcription factors to reprogram human induced pluripotent stem cells (hiPSCs) into engineered ovarian and endometrial cell lines that function similarly to natural cells. This platform supports a portfolio of cellular therapeutics targeting various female reproductive diseases. Gameto's flagship program, Fertilo, is designed to enhance the processes of in vitro fertilization (IVF) and egg freezing, making them shorter, safer, and more effective. Additional applications of Gameto's technology include Deovo, an organoid of the female reproductive system, and Ameno, a cell-based therapeutic aimed at alleviating the health issues associated with primary ovarian insufficiency and menopause.

Viome

Series C in 2021
Viome, Inc. is a biotechnology company based in Bellevue, Washington, founded in 2016 by Naveen Jain. The company specializes in wellness monitoring kits that offer comprehensive health insights by analyzing various biological samples, including blood, urine, saliva, and stool. By examining the RNA from stool samples, Viome determines the composition of microbial communities in the digestive system, identifying different species and strains of bacteria, viruses, fungi, and other microorganisms. This analysis is integrated into a smartphone application that provides personalized recommendations for diet and lifestyle adjustments, aiding users in tracking their microbiome health, mitochondrial health, cellular health, and biological age. Viome's products are available through distributors and online, positioning the company as a leader in personalized health solutions.

MagicCube

Series C in 2021
MagicCube is a developer of a security platform that focuses on protecting digital transactions against various threats, including on-device, cloud, and network attacks. Its technology, based on a software TEE (Trusted Execution Environment), allows for the secure management and deployment of IoT and mobile solutions on a large scale. Unlike traditional hardware-based security tools, MagicCube's platform offers a comparable level of protection without the associated complexities and costs, making it easier for businesses to safeguard their operations. This innovative approach helps to prevent significant security issues such as cloning, lifting, spoofing, and tampering, thereby enhancing the overall security posture of its clients.

Meru Health

Series B in 2021
Meru Health, Inc. is a digital healthcare company that focuses on improving the lives of individuals dealing with mental health issues such as depression, anxiety, and stress. Founded in 2015 and based in San Mateo, California, with additional offices in Palo Alto and Helsinki, Meru Health develops a mobile application that connects users to licensed therapists through a structured 12-week program. This program combines continuous remote clinician support with at-home lessons, cognitive behavioral therapy, and coaching on sleep and nutrition. By offering clinically proven and cost-effective digital therapeutic solutions, Meru Health aims to empower patients and enhance the efficiency of mental health treatment.

Elevian

Series A in 2021
Elevian, Inc. is a biotechnology company based in Menlo Park, California, founded in 2017. The company focuses on developing medicines that aim to restore regenerative capacity and address age-related diseases. Elevian's research centers on the Growth Differentiation Factor 11 (GDF11) protein and other circulating blood factors that stimulate regeneration in various tissues, including the brain, heart, pancreas, and muscle. Its therapeutics are designed to target the underlying mechanisms of aging, with applications in stroke recovery, Alzheimer's disease, coronary artery disease, and Type 2 diabetes. Through its innovative approach, Elevian seeks to prevent and treat the effects of aging by enhancing the body's natural repair and regeneration processes.

Curebase

Series A in 2021
Curebase is a company that develops software aimed at transforming the management of clinical trials. Founded in 2017 and based in San Francisco, California, its platform facilitates faster and more cost-effective trial execution by streamlining participant eligibility, enrollment, education, and consent processes. The software automates many manual steps and allows drug companies to efficiently distribute their trials to clinics. Additionally, it provides sponsors with access to real-time data, enabling them to monitor trial progress and manage information effectively. Curebase's services cater to various sectors, including medical devices, biotechnology, and digital health startups, enhancing the overall efficiency of clinical research.

Docbot

Series A in 2021
Docbot, Inc. is an artificial intelligence technology company based in Irvine, California, that specializes in gastrointestinal diseases. The company develops web-based applications for iOS and Android devices, offering a clinical decision support system that aggregates patient information and provides cloud analytics for healthcare professionals. Its flagship product is built on the UltivisionAI software platform, which focuses on real-time image analysis and automated reporting. This platform is designed to detect colorectal cancer and other gastrointestinal conditions by integrating various data sources from imaging systems and pathology requisitions. Docbot aims to enhance patient care and streamline clinical workflows, ultimately reducing cancer risks and improving outcomes for patients in the gastrointestinal specialty.

Chef Robotics

Seed Round in 2021
Chef Robotics is a robotics and artificial intelligence company serving the food industry. The company was founded in 2019 and is headquartered in San Francisco, California.

SeQure Dx

Venture Round in 2021
SeQure Dx specializes in providing safety data related to CRISPR gene editing therapies, focusing on both on-target and off-target effects. The company develops genomics diagnostic technologies that facilitate target profiling for gene editing, supporting the discovery, clinical development, and diagnostic processes. Its core technologies are designed to identify potential off-target sites prior to the initiation of therapy, ensuring comprehensive confirmation of actual genetic edits. This capability empowers gene editing therapeutics developers, physicians, and patients by enhancing the safety and efficacy of gene editing treatments.

Bionaut Labs

Series A in 2021
Bionaut Labs, Inc. is a biotechnology company based in Palo Alto, California, founded in 2016. The company specializes in developing a novel intra-tissue navigation platform utilizing Bionaut nano/micro robots that operate within the body. This innovative technology enables precise anatomical targeting for the treatment of central nervous system disorders, offering a new approach to precision medicine. By employing remote-controlled micro-robots, Bionaut Labs enhances the development of therapeutics, making advanced technologies like gene therapy and CRISPR-Cas9 feasible in challenging clinical scenarios. The Bionaut platform allows medical professionals to access any anatomic location within the body, facilitating the automation of complex procedures while eliminating the need for external incisions, thereby improving patient outcomes for those with limited treatment options.

Mighty Buildings

Series B in 2021
Mighty Buildings, Inc. is a construction technology company based in San Francisco, California, founded in 2017. The company specializes in manufacturing 3D printed custom homes, aiming to disrupt the residential housing market through innovative techniques. Utilizing a proprietary building material known as Light Stone Material (LSM), which resembles synthetic stone, Mighty Buildings enhances the construction process by making it faster and eliminating waste. LSM also offers better temperature regulation compared to traditional materials like concrete, wood, or steel. In addition to 3D printing, Mighty Buildings employs robotics and automation to develop prefabricated, environmentally friendly, and climate-resilient homes. The company's approach to modular construction is designed to provide affordable smart housing solutions while supporting urban development.

Crowdz

Series A in 2020
Crowdz is a company focused on modernizing the traditional trade finance industry through innovative invoicing software. By automating risk assessment at the receivable level, Crowdz provides funders with valuable insights that facilitate quick decision-making aligned with their investment strategies. The company has auto risk-rated $4.2 billion in receivables, leading to over $93 million in financing through its platform. Its technology bridges real-world assets with decentralized finance by digitizing receivables on-chain, thereby enabling small and midsize enterprises to access essential business financing and enhance their competitive edge. Crowdz has garnered significant support from notable customers and investors, including Citibank, Barclays, and Meta, and has raised over $28 million in funding to date.

Elevian

Venture Round in 2020
Elevian, Inc. is a biotechnology company based in Menlo Park, California, founded in 2017. The company focuses on developing medicines that aim to restore regenerative capacity and address age-related diseases. Elevian's research centers on the Growth Differentiation Factor 11 (GDF11) protein and other circulating blood factors that stimulate regeneration in various tissues, including the brain, heart, pancreas, and muscle. Its therapeutics are designed to target the underlying mechanisms of aging, with applications in stroke recovery, Alzheimer's disease, coronary artery disease, and Type 2 diabetes. Through its innovative approach, Elevian seeks to prevent and treat the effects of aging by enhancing the body's natural repair and regeneration processes.

AliveCor

Series E in 2020
AliveCor, Inc. develops advanced mobile electrocardiogram (ECG) technology that transforms smartphones into clinical-quality heart monitoring devices. The company offers KardiaMobile, a personal ECG device for the instant detection of common heart arrhythmias, along with KardiaMobile 6L, which provides detailed 6-lead ECGs that patients can share with their healthcare providers. Additionally, AliveCor has introduced KardiaCare, a digital health subscription service that allows users to manage their heart health conveniently at home. Founded in 2010 and headquartered in Mountain View, California, AliveCor is recognized for its innovative use of machine learning techniques to enhance proactive heart care and improve stroke prevention through early atrial fibrillation detection.

Solarea Bio

Series A in 2020
Solarea Bio is a biotech company that develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health. It specializes in the research and development of therapeutics that are derived from natural sources and are aimed to treat indications derived from chronic inflammation, enabling hospitals to provide medicinal drugs for improved quality of life. The company generates a large database of the complete genomic sequences of microbes derived from healthy foods. Using computational approaches, Solarea generates synergistic combinations of bacteria, fungi, and prebiotic fibers with powerful anti-inflammatory capabilities to address specific chronic conditions that afflict large numbers of people. These have been validated in-vitro and in-vivo in preclinical mouse models. Its first application aims to aid in the dietary management of the metabolic processes that cause osteopenia and osteoporosis in postmenopausal women. This provides a nature-based solution to improving women’s health and well-being. The Cambridge, Massachusetts-based company was established in 2017 by Eric Schott, Gerardo Toledo, and Jillian DeWalt.

Symbiome

Venture Round in 2020
Symbiome, Inc. is a skincare company based in San Francisco, California, that develops and sells products formulated with microbiomic and plant-based ingredients. Founded in 2017 and originally named Persona Biome, Inc., the company rebranded to Symbiome in December 2019. Its product line emphasizes the use of scientifically proven ancestral ingredients, aiming to replace modern chemicals and provide customers with organic solutions for skin care. By focusing on clarity, vibrance, and resilience, Symbiome offers a natural approach to skincare that meets diverse customer needs.

Deep Longevity

Series A in 2020
Deep Longevity, Inc. is a biotechnology company focused on advancing aging and longevity research through the development of aging clocks and biomarkers. Founded in 2016 and based in Hong Kong, the company offers a range of products including the Longevity Cloud, which hosts deep aging clocks, and Young.AI, a web and mobile application designed to assist individuals in monitoring their biological age. Deep Longevity also provides AgeMetric Reports for tracking longevity and employs an AI-based recommendation engine to suggest interventions for improving health outcomes. Its comprehensive approach incorporates various data types such as clinical blood tests, transcriptomic, proteomic, and microbiome information, enabling healthcare providers and aging centers to predict biological age with greater accuracy and support preventative medicine initiatives.

Proprio

Series A in 2020
Proprio, Inc. is a Seattle-based company that develops advanced surgical technology aimed at enhancing surgical accuracy, simplifying workflows, and improving patient outcomes. Founded in 2016, Proprio utilizes machine learning, artificial intelligence, and mixed-reality user interfaces to create a next-generation surgical navigation and imaging platform. This innovative system replaces traditional surgical microscopes, loupes, and navigation systems by offering networked camera arrays and depth-sensing technology, allowing users to navigate live 3D environments with depth perception from any angle. Proprio's goal extends beyond merely replacing existing technologies; it seeks to advance medicine by integrating the latest digital innovations, moving away from outdated practices and focusing on software and data to improve surgical practices and outcomes.

MagicCube

Series B in 2020
MagicCube is a developer of a security platform that focuses on protecting digital transactions against various threats, including on-device, cloud, and network attacks. Its technology, based on a software TEE (Trusted Execution Environment), allows for the secure management and deployment of IoT and mobile solutions on a large scale. Unlike traditional hardware-based security tools, MagicCube's platform offers a comparable level of protection without the associated complexities and costs, making it easier for businesses to safeguard their operations. This innovative approach helps to prevent significant security issues such as cloning, lifting, spoofing, and tampering, thereby enhancing the overall security posture of its clients.

Gali Health

Seed Round in 2020
At Gali Health, we are on a mission to make sure nobody ever feels isolated, lost or powerless in the face of existing or potential disease. We are working to advance consumer-powered healthcare by crowdsourcing personal health data and medically-validated insights, applying AI to process them and providing highly personalized informational support on the medical, lifestyle and psychological aspects of living with chronic disease. Our mobile personal health assistant named Gali relies on collective intelligence to help people with chronic conditions proactively manage their health.

Meru Health

Series A in 2020
Meru Health, Inc. is a digital healthcare company that focuses on improving the lives of individuals dealing with mental health issues such as depression, anxiety, and stress. Founded in 2015 and based in San Mateo, California, with additional offices in Palo Alto and Helsinki, Meru Health develops a mobile application that connects users to licensed therapists through a structured 12-week program. This program combines continuous remote clinician support with at-home lessons, cognitive behavioral therapy, and coaching on sleep and nutrition. By offering clinically proven and cost-effective digital therapeutic solutions, Meru Health aims to empower patients and enhance the efficiency of mental health treatment.

Chef Robotics

Seed Round in 2020
Chef Robotics is a robotics and artificial intelligence company serving the food industry. The company was founded in 2019 and is headquartered in San Francisco, California.

Pyka

Seed Round in 2019
Pyka, Inc. is a startup based in Oakland, California, that specializes in the development of autonomous electric aircraft for agricultural and cargo applications. Founded in 2016, the company focuses on creating innovative solutions that enhance safety, affordability, and accessibility in aviation. Pyka's aircraft are designed for precision spraying in agriculture, allowing for effective chemical application over diverse terrains while minimizing environmental impact. The technology incorporates advanced flight controllers and onboard sensors to ensure accuracy and efficiency in operations. Additionally, the aircraft can be utilized for cargo transportation, particularly in remote or challenging areas, showcasing their versatility. Through its commitment to sustainability and technological advancement, Pyka aims to transform traditional practices in crop protection and logistics.

GuRu

Series A in 2019
GuRu Wireless, Inc. enables safe, effective and customizable transmission of power over-the-air using proprietary millimeter-wave (mmWave) integrated circuits, modules and proprietary Smart RF Lensing technology. A miniature-sized power transfer system delivers power at an unprecedented distance efficiently and with precision. GuRu's wireless solution can be used as a charging hub or a power source in many settings where access to an energy source is needed. It is easy to install, safe, and sophisticated enough to find and adjust for various power levels to sync with the needs of any device. Even during use, it continuously charges devices and as a safety measure, reroutes power as necessary. Founded in 2017 by a team of scientists and engineers from Caltech, GuRu aims to ensure access to power be as ubiquitous as WiFi.

Metawave

Series A in 2019
Metawave Corporation, founded in 2017 and based in Palo Alto, California, specializes in developing advanced beamsteering radars that utilize metamaterials and artificial intelligence for the automotive industry. The company focuses on enhancing safety and connectivity in autonomous driving through its flagship radar platform, SPEKTRA, which enables 3D imaging and vehicle-to-vehicle communications. Additionally, Metawave offers TURBO active repeaters to improve signal coverage in challenging environments and ECHO passive reflectors that help direct signals in areas with limited connectivity. The company is also advancing wireless communications by creating smart beamsteering antennas designed for 4G and 5G networks, aiming to support faster connectivity for a wide range of users. Metawave's innovative technology originated from research at Xerox PARC, reflecting its commitment to revolutionizing the future of transportation and communications.

Insilico Medicine

Series B in 2019
Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.

ParkourSC

Series B in 2019
ParkourSC is a logistics and supply chain company founded in 2014 and headquartered in Milpitas, California. The company focuses on digital transformation within the manufacturing and pharmaceutical sectors by offering a cloud-based sensor platform. This platform creates a digital twin of the supply chain, processing billions of events per second to provide real-time diagnostic and predictive insights regarding asset location, condition, utilization, and anomaly detection. By collecting data from various sources, ParkourSC enables continuous visibility into the context and timing of materials and assets, allowing businesses to proactively predict disruptions and enhance operational efficiency.

Mighty Buildings

Series A in 2019
Mighty Buildings, Inc. is a construction technology company based in San Francisco, California, founded in 2017. The company specializes in manufacturing 3D printed custom homes, aiming to disrupt the residential housing market through innovative techniques. Utilizing a proprietary building material known as Light Stone Material (LSM), which resembles synthetic stone, Mighty Buildings enhances the construction process by making it faster and eliminating waste. LSM also offers better temperature regulation compared to traditional materials like concrete, wood, or steel. In addition to 3D printing, Mighty Buildings employs robotics and automation to develop prefabricated, environmentally friendly, and climate-resilient homes. The company's approach to modular construction is designed to provide affordable smart housing solutions while supporting urban development.

Gallant Pet

Series A in 2019
Gallant Pet, Inc. is a pet service company based in San Diego, California, that specializes in stem cell preservation services for dogs. Founded in 2018, the company collects and banks stem cells from tissue during routine spay or neuter procedures. Gallant Pet also provides a platelet-rich plasma (PRP) kit for dogs suffering from osteoarthritis and other musculoskeletal issues. In addition to its preservation services, the company is engaged in clinical research to develop effective stem cell therapies for various conditions. Through its innovative approach, Gallant Pet enables pet owners to preserve their pets' young stem cells for future medical treatments.

Gali Health

Seed Round in 2019
At Gali Health, we are on a mission to make sure nobody ever feels isolated, lost or powerless in the face of existing or potential disease. We are working to advance consumer-powered healthcare by crowdsourcing personal health data and medically-validated insights, applying AI to process them and providing highly personalized informational support on the medical, lifestyle and psychological aspects of living with chronic disease. Our mobile personal health assistant named Gali relies on collective intelligence to help people with chronic conditions proactively manage their health.

Viome

Series B in 2019
Viome, Inc. is a biotechnology company based in Bellevue, Washington, founded in 2016 by Naveen Jain. The company specializes in wellness monitoring kits that offer comprehensive health insights by analyzing various biological samples, including blood, urine, saliva, and stool. By examining the RNA from stool samples, Viome determines the composition of microbial communities in the digestive system, identifying different species and strains of bacteria, viruses, fungi, and other microorganisms. This analysis is integrated into a smartphone application that provides personalized recommendations for diet and lifestyle adjustments, aiding users in tracking their microbiome health, mitochondrial health, cellular health, and biological age. Viome's products are available through distributors and online, positioning the company as a leader in personalized health solutions.

Mojo Vision

Series B in 2019
Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.

Docbot

Seed Round in 2019
Docbot, Inc. is an artificial intelligence technology company based in Irvine, California, that specializes in gastrointestinal diseases. The company develops web-based applications for iOS and Android devices, offering a clinical decision support system that aggregates patient information and provides cloud analytics for healthcare professionals. Its flagship product is built on the UltivisionAI software platform, which focuses on real-time image analysis and automated reporting. This platform is designed to detect colorectal cancer and other gastrointestinal conditions by integrating various data sources from imaging systems and pathology requisitions. Docbot aims to enhance patient care and streamline clinical workflows, ultimately reducing cancer risks and improving outcomes for patients in the gastrointestinal specialty.

Iota Biosciences

Series A in 2018
Iota Biosciences, Inc. is a medical device company based in Berkeley, California, founded in 2017. It specializes in the development of wireless sensors and devices aimed at monitoring, measuring, and stimulating internal nerves, muscles, and organs for electroceutical applications, particularly in the treatment of immune and neural disorders. The company has pioneered neural dust technology, utilizing implantable, mote-sized ultrasonic sensors that enable untethered and real-time wireless cortical recordings, improving the methods by which physicians monitor and treat various diseases. Iota's mission is to create safe and effective bioelectronic devices that transform disease management and enhance patient care. As a subsidiary of Astellas Pharma, Iota is committed to leveraging innovative science and technology to advance the field of bioelectronics and make a meaningful impact on patients' lives.

Octi

Seed Round in 2018
Octi is the world’s first augmented reality social platform where reality merges with the metaverse and empowers anyone to create vibrant content with digital objects and scenes, rewarding creators with virtual and physical goods from leading brands. Octi’s independent Los Angeles-based team builds and combines the latest in machine learning, computer vision, and AR technologies to deliver the killer applications of the future.

Oura

Series A in 2018
Oura is a Finland-based company that specializes in developing a smart wellness ring designed to monitor and track various biometric data related to health and wellness. The ring, paired with a smartphone application, enables users to gain insights into their sleep patterns, readiness, and activity levels. By utilizing advanced sensors, the device collects information on heart rate, sleep cycles, and overall activity, providing users with valuable physiological and behavioral data. This innovative approach supports individuals in understanding their body's responses to rest, recovery, and daily activities, thus promoting a healthier lifestyle.

IVIVA

Seed Round in 2018
IVIVA Medical focuses on developing autologous tissue constructs to address end-stage renal disease (ESRD), a condition affecting over 500,000 patients in the United States. As transplant remains the only definitive treatment for ESRD, the majority of patients do not receive donor kidneys. The company utilizes advanced technologies in tissue engineering, 3D additive manufacturing, and stem cell biology to create bioartificial platforms that not only provide therapeutic solutions but also lay the groundwork for future engineered functional tissues. Through these innovations, IVIVA aims to contribute to the field of regenerative medicine and help alleviate the shortage of donor organs.

Synadia

Seed Round in 2018
Synadia Communications Inc. is a technology company based in Los Angeles, California, focused on developing a global utility platform for connecting digital systems, services, and devices. Established in 2017, Synadia is the leader in the development of NATS.io, an open-source messaging system designed for cloud-native applications, microservices architectures, and Internet of Things (IoT) messaging. The company offers NGS, a secure and globally available communications platform built on NATS.io, along with additional services such as commercial support, consulting, non-recurring engineering, and training. By leveraging its innovative technology, Synadia aims to provide scalable and secure messaging solutions that facilitate modern distributed systems across various applications.

Exo

Series A in 2017
Exo is a medical device startup focused on developing a handheld ultrasound platform for imaging and therapeutic applications. The company aims to provide affordable and user-friendly medical imaging solutions for healthcare professionals globally. By integrating advanced nano-materials, innovative sensor technologies, and sophisticated signal processing with the cost efficiencies of semiconductor manufacturing, Exo significantly lowers the costs associated with medical imaging. This technology allows healthcare providers to make vital, real-time decisions that enhance patient outcomes. Exo's commitment to high-quality, accessible imaging represents a significant advancement in medical technology, making effective diagnostic tools available at an unprecedented price point.

Dreamscape Immersive

Series B in 2017
Dreamscape Immersive is a company that uses VR technologies to create an entirely new form of mainstream location-based entertainment. The company was incorporated in 2016 and is based in Santa Monica, California.

ParkourSC

Series A in 2017
ParkourSC is a logistics and supply chain company founded in 2014 and headquartered in Milpitas, California. The company focuses on digital transformation within the manufacturing and pharmaceutical sectors by offering a cloud-based sensor platform. This platform creates a digital twin of the supply chain, processing billions of events per second to provide real-time diagnostic and predictive insights regarding asset location, condition, utilization, and anomaly detection. By collecting data from various sources, ParkourSC enables continuous visibility into the context and timing of materials and assets, allowing businesses to proactively predict disruptions and enhance operational efficiency.

GuRu

Seed Round in 2017
GuRu Wireless, Inc. enables safe, effective and customizable transmission of power over-the-air using proprietary millimeter-wave (mmWave) integrated circuits, modules and proprietary Smart RF Lensing technology. A miniature-sized power transfer system delivers power at an unprecedented distance efficiently and with precision. GuRu's wireless solution can be used as a charging hub or a power source in many settings where access to an energy source is needed. It is easy to install, safe, and sophisticated enough to find and adjust for various power levels to sync with the needs of any device. Even during use, it continuously charges devices and as a safety measure, reroutes power as necessary. Founded in 2017 by a team of scientists and engineers from Caltech, GuRu aims to ensure access to power be as ubiquitous as WiFi.

Metawave

Seed Round in 2017
Metawave Corporation, founded in 2017 and based in Palo Alto, California, specializes in developing advanced beamsteering radars that utilize metamaterials and artificial intelligence for the automotive industry. The company focuses on enhancing safety and connectivity in autonomous driving through its flagship radar platform, SPEKTRA, which enables 3D imaging and vehicle-to-vehicle communications. Additionally, Metawave offers TURBO active repeaters to improve signal coverage in challenging environments and ECHO passive reflectors that help direct signals in areas with limited connectivity. The company is also advancing wireless communications by creating smart beamsteering antennas designed for 4G and 5G networks, aiming to support faster connectivity for a wide range of users. Metawave's innovative technology originated from research at Xerox PARC, reflecting its commitment to revolutionizing the future of transportation and communications.

MagicCube

Series A in 2017
MagicCube is a developer of a security platform that focuses on protecting digital transactions against various threats, including on-device, cloud, and network attacks. Its technology, based on a software TEE (Trusted Execution Environment), allows for the secure management and deployment of IoT and mobile solutions on a large scale. Unlike traditional hardware-based security tools, MagicCube's platform offers a comparable level of protection without the associated complexities and costs, making it easier for businesses to safeguard their operations. This innovative approach helps to prevent significant security issues such as cloning, lifting, spoofing, and tampering, thereby enhancing the overall security posture of its clients.

Viome

Series A in 2017
Viome, Inc. is a biotechnology company based in Bellevue, Washington, founded in 2016 by Naveen Jain. The company specializes in wellness monitoring kits that offer comprehensive health insights by analyzing various biological samples, including blood, urine, saliva, and stool. By examining the RNA from stool samples, Viome determines the composition of microbial communities in the digestive system, identifying different species and strains of bacteria, viruses, fungi, and other microorganisms. This analysis is integrated into a smartphone application that provides personalized recommendations for diet and lifestyle adjustments, aiding users in tracking their microbiome health, mitochondrial health, cellular health, and biological age. Viome's products are available through distributors and online, positioning the company as a leader in personalized health solutions.

Exo

Venture Round in 2017
Exo is a medical device startup focused on developing a handheld ultrasound platform for imaging and therapeutic applications. The company aims to provide affordable and user-friendly medical imaging solutions for healthcare professionals globally. By integrating advanced nano-materials, innovative sensor technologies, and sophisticated signal processing with the cost efficiencies of semiconductor manufacturing, Exo significantly lowers the costs associated with medical imaging. This technology allows healthcare providers to make vital, real-time decisions that enhance patient outcomes. Exo's commitment to high-quality, accessible imaging represents a significant advancement in medical technology, making effective diagnostic tools available at an unprecedented price point.

Terramera

Venture Round in 2016
Terramera, Inc. is a Vancouver-based company that develops and manufactures plant-based pesticides and fertilizers. Founded in 2009, it focuses on providing alternatives to conventional chemical products in agriculture. The company's offerings include Proof, a solution for bed bugs and dust mites; Actigate, an organic pesticide; and Rango, a pest control and crop protection product. Terramera integrates artificial intelligence with scientific principles and nature to create innovative agriculture technology platforms. Its mission is to transform food production while ensuring a healthy, safe environment free from toxic chemicals, ultimately supporting sustainable and organic farming practices that enhance yields and profitability for farmers and growers.

Epharmix

Seed Round in 2016
Epharmix is a digital healthcare company that creates clinically validated and condition-specific communication tools. It helps care teams automatically monitor underserved patients to improve care & reduce workload with interventions proven to impact engagement and outcomes. It was founded in 2015 and headquartered in St Louis, Missouri.

Meta View

Series B in 2016
Meta View is an electronic company that provides augmented and virtual reality solutions for various businesses in the United States. It offers wearable devices that provide augmented and virtual reality experience and other gadgets based on machine learning and artificial intelligence. Ben Sand, Meron Gribetz, and Raymond Lo founded Meta View in 2019. It has its headquarters in San Mateo in California.

Terramera

Venture Round in 2016
Terramera, Inc. is a Vancouver-based company that develops and manufactures plant-based pesticides and fertilizers. Founded in 2009, it focuses on providing alternatives to conventional chemical products in agriculture. The company's offerings include Proof, a solution for bed bugs and dust mites; Actigate, an organic pesticide; and Rango, a pest control and crop protection product. Terramera integrates artificial intelligence with scientific principles and nature to create innovative agriculture technology platforms. Its mission is to transform food production while ensuring a healthy, safe environment free from toxic chemicals, ultimately supporting sustainable and organic farming practices that enhance yields and profitability for farmers and growers.

Singularity University

Series A in 2016
Singularity University, officially known as Singularity Education Group, is a benefit corporation based in Santa Clara, California, founded in 2008. It operates as a learning and innovation community that collaborates with entrepreneurs, corporations, nonprofits, governments, investors, and academic institutions. The organization provides a range of educational programs, including executive and exponential innovation programs, an incubator, and a global startup program. Its offerings encompass online courses focused on exponential thinking and behavioral transformation, as well as international summits and events aimed at fostering collaboration and innovation. Singularity University aims to equip individuals and organizations with the knowledge and tools to leverage advanced technologies such as artificial intelligence, robotics, and biotechnology to address significant global challenges like education, health, and environmental sustainability. Through its global network, which includes numerous chapters and alumni, Singularity University seeks to inspire and empower individuals to create impactful solutions that benefit humanity.

BlueLine Grid

Venture Round in 2016
BlueLine Grid, Inc. is a provider of mobile solutions that connects law enforcement, emergency services, security teams, and government agencies across the United States. Founded in 2013 and headquartered in Annapolis, Maryland, the company offers an encrypted suite of tools designed for secure communication and collaboration. These tools include messaging, voice, location services, conferencing, and file-sharing capabilities, tailored to meet the needs of public and private security officials. One of their key offerings is GridTeam, a mobile application that enables users to connect based on area, organization, proximity, or specialty. Additionally, the company provides a Grid bot for Microsoft Skype, allowing users to engage in mass notifications and group conference calls seamlessly. BlueLine Grid aims to enhance communication and operational efficiency for its clients while ensuring privacy and compliance.

CloudMondo

Venture Round in 2016
CloudMondo is a technology startup located in Silicon Valley, specializing in an online marketplace for Over-The-Top (OTT) network services. The company has developed a cloud-based platform designed to enhance global internet connectivity, viewing access to the internet as a fundamental human right. This innovative platform utilizes artificial intelligence, open-source technology, virtualization, and software-defined networking to provide affordable and interactive broadband solutions. By addressing the cost and complexity barriers associated with connectivity, CloudMondo aims to deliver highly accessible broadband services. The company also offers a suite of OTT services that enable various entities, including municipalities, service providers, and businesses, to generate revenue while providing interactive access to their users. Currently, CloudMondo's solutions are operational in 12 countries across four continents, reflecting its commitment to enhancing digital connectivity worldwide.

Kindred AI

Series A in 2015
Kindred's mission is to build machines with human-like intelligence. Since its founding in 2014, Kindred has been exploring and engineering systems that enable robots to interact with the physical world, fulfilling the goal of bringing humans and intelligent machines together to solve real-world problems. Kindred has built an AI platform that integrates vision, grasping and placement to create autonomous solutions for complex commercial problems. With increased labor complexities in e-commerce fulfillment centers, Kindred developed a flagship product, SORT, to help retailers stay competitive. Kindred smart piece-picking SORT robots tackle a labor intensive part of the supply chain, which is Putwall Sortation, completing the manual task to pick and place items into separate customer orders. Kindred robots are currently in commercial use at e-commerce leaders including Gap, Inc., Carter’s and other global retailers. The Kindred SORT robots work alongside warehouse staff to quickly and accurately sort items into individual customer orders. Kindred has offices in San Francisco & Toronto.

Meta View

Series A in 2015
Meta View is an electronic company that provides augmented and virtual reality solutions for various businesses in the United States. It offers wearable devices that provide augmented and virtual reality experience and other gadgets based on machine learning and artificial intelligence. Ben Sand, Meron Gribetz, and Raymond Lo founded Meta View in 2019. It has its headquarters in San Mateo in California.

ParkourSC

Seed Round in 2014
ParkourSC is a logistics and supply chain company founded in 2014 and headquartered in Milpitas, California. The company focuses on digital transformation within the manufacturing and pharmaceutical sectors by offering a cloud-based sensor platform. This platform creates a digital twin of the supply chain, processing billions of events per second to provide real-time diagnostic and predictive insights regarding asset location, condition, utilization, and anomaly detection. By collecting data from various sources, ParkourSC enables continuous visibility into the context and timing of materials and assets, allowing businesses to proactively predict disruptions and enhance operational efficiency.

AliveCor

Series B in 2012
AliveCor, Inc. develops advanced mobile electrocardiogram (ECG) technology that transforms smartphones into clinical-quality heart monitoring devices. The company offers KardiaMobile, a personal ECG device for the instant detection of common heart arrhythmias, along with KardiaMobile 6L, which provides detailed 6-lead ECGs that patients can share with their healthcare providers. Additionally, AliveCor has introduced KardiaCare, a digital health subscription service that allows users to manage their heart health conveniently at home. Founded in 2010 and headquartered in Mountain View, California, AliveCor is recognized for its innovative use of machine learning techniques to enhance proactive heart care and improve stroke prevention through early atrial fibrillation detection.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.